These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 24477201)
1. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency department. Di Somma S; Lalle I; Magrini L; Russo V; Navarin S; Castello L; Avanzi GC; Di Stasio E; Maisel A Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):167-75. PubMed ID: 24477201 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure. Santarelli S; Russo V; Lalle I; De Berardinis B; Navarin S; Magrini L; Piccoli A; Codognotto M; Castello LM; Avanzi GC; Villacorta H; Precht BLC; de Araújo Porto PB; Villacorta AS; Di Somma S; Intern Emerg Med; 2017 Jun; 12(4):445-451. PubMed ID: 27987064 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of decreased peripheral congestion detected by Bioelectrical Impedance Vector Analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure. Santarelli S; Russo V; Lalle I; De Berardinis B; Vetrone F; Magrini L; Di Stasio E; Piccoli A; Codognotto M; Mion MM; Castello LM; Avanzi GC; Di Somma S; Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):339-347. PubMed ID: 27073131 [TBL] [Abstract][Full Text] [Related]
4. Bioelectrical impedance analysis for heart failure diagnosis in the ED. Génot N; Mewton N; Bresson D; Zouaghi O; Francois L; Delwarde B; Kirkorian G; Bonnefoy-Cudraz E Am J Emerg Med; 2015 Aug; 33(8):1025-9. PubMed ID: 25959843 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure. Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A; Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure. Massari F; Iacoviello M; Scicchitano P; Mastropasqua F; Guida P; Riccioni G; Speziale G; Caldarola P; Ciccone MM; Di Somma S Heart Lung; 2016; 45(4):319-26. PubMed ID: 27117421 [TBL] [Abstract][Full Text] [Related]
7. Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure. Liu MH; Wang CH; Huang YY; Tung TH; Lee CM; Yang NI; Liu PC; Cherng WJ J Cardiovasc Med (Hagerstown); 2012 May; 13(5):299-306. PubMed ID: 22367574 [TBL] [Abstract][Full Text] [Related]
8. Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. Maisel AS; Peacock WF; Shah KS; Clopton P; Diercks D; Hiestand B; Kontos MC; Mueller C; Nowak R; Chen WJ; Collins SP Am J Emerg Med; 2011 Oct; 29(8):924-31. PubMed ID: 20627217 [TBL] [Abstract][Full Text] [Related]
9. Serum biochemical determinants of peripheral congestion assessed by bioimpedance vector analysis in acute heart failure. Massari F; Scicchitano P; Iacoviello M; Valle R; Sanasi M; Piscopo A; Guida P; Mastropasqua F; Caldarola P; Ciccone MM Heart Lung; 2019; 48(5):395-399. PubMed ID: 31113676 [TBL] [Abstract][Full Text] [Related]
11. Use of BNP and bioimpedance to drive therapy in heart failure patients. Di Somma S; De Berardinis B; Bongiovanni C; Marino R; Ferri E; Alfei B Congest Heart Fail; 2010 Jul; 16 Suppl 1():S56-61. PubMed ID: 20653713 [TBL] [Abstract][Full Text] [Related]
12. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study. Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372 [TBL] [Abstract][Full Text] [Related]
13. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528 [TBL] [Abstract][Full Text] [Related]
14. Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. Arenja N; Reichlin T; Drexler B; Oshima S; Denhaerynck K; Haaf P; Potocki M; Breidthardt T; Noveanu M; Stelzig C; Heinisch C; Twerenbold R; Reiter M; Socrates T; Mueller C J Intern Med; 2012 Jun; 271(6):598-607. PubMed ID: 21988283 [TBL] [Abstract][Full Text] [Related]
15. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R; J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum cystatin C and N-terminal pro b-type natriuretic peptide in patients with acute heart failure. Pérez-Calvo JI; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Manzano-Fernández S; Galisteo-Almeda L; Pascual-Figal D Eur J Intern Med; 2012 Oct; 23(7):599-603. PubMed ID: 22939803 [TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure. De Berardinis B; Magrini L; Zampini G; Zancla B; Salerno G; Cardelli P; Di Stasio E; Gaggin HK; Belcher A; Parry BA; Nagurney JT; Januzzi JL; Di Somma S Biomed Res Int; 2014; 2014():983098. PubMed ID: 25101304 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study). O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]